Imugene Limited (IMU.AX)
AUD 0.04
(-5.26%)
AUD 0.04
(-5.26%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 | 33.14 Million AUD | 345.66% |
| 2023 | 7.43 Million AUD | -16.45% |
| 2022 | 8.9 Million AUD | 31.06% |
| 2021 | 6.79 Million AUD | 25.8% |
| 2020 | 5.39 Million AUD | 54.93% |
| 2019 | 3.48 Million AUD | 142.19% |
| 2018 | 1.43 Million AUD | 12.15% |
| 2017 | 1.28 Million AUD | -23.6% |
| 2016 | 1.67 Million AUD | 21.45% |
| 2015 | 1.38 Million AUD | -27.2% |
| 2014 | 1.89 Million AUD | 172.09% |
| 2013 | 698.02 Thousand AUD | 184.94% |
| 2012 | 244.97 Thousand AUD | -48.99% |
| 2011 | 480.27 Thousand AUD | 56.25% |
| 2010 | 307.37 Thousand AUD | -29.62% |
| 2009 | 436.71 Thousand AUD | -11.48% |
| 2008 | 493.36 Thousand AUD | -11.99% |
| 2007 | 560.55 Thousand AUD | -30.46% |
| 2006 | 806.04 Thousand AUD | 95.87% |
| 2005 | 411.52 Thousand AUD | -29.57% |
| 2004 | 584.29 Thousand AUD | -16.62% |
| 2003 | 700.76 Thousand AUD | 1259.15% |
| 2002 | 51.55 Thousand AUD | -98.07% |
| 2001 | 2.66 Million AUD | 195.33% |
| 2000 | 903.08 Thousand AUD | 0.57% |
| 1999 | 898 Thousand AUD | -20.95% |
| 1998 | 1.13 Million AUD | -8.46% |
| 1997 | 1.24 Million AUD | 10.12% |
| 1996 | 1.12 Million AUD | -13.64% |
| 1995 | 1.3 Million AUD | 927.56% |
| 1994 | 127 Thousand AUD | -78.36% |
| 1993 | 587 Thousand AUD | 0.0% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 Q2 | 35.59 Million AUD | 0.0% |
| 2024 FY | 33.14 Million AUD | 345.66% |
| 2024 Q4 | 33.14 Million AUD | 0.0% |
| 2023 Q2 | 5.14 Million AUD | 0.0% |
| 2023 Q4 | 7.43 Million AUD | 0.0% |
| 2023 FY | 7.43 Million AUD | -16.45% |
| 2022 FY | 8.9 Million AUD | 31.06% |
| 2022 Q2 | 7.77 Million AUD | 0.0% |
| 2022 Q4 | 8.9 Million AUD | 0.0% |
| 2021 FY | 6.79 Million AUD | 25.8% |
| 2021 Q2 | 4.75 Million AUD | 0.0% |
| 2021 Q4 | 6.79 Million AUD | 0.0% |
| 2020 FY | 5.39 Million AUD | 54.93% |
| 2020 Q4 | 5.39 Million AUD | 0.0% |
| 2020 Q2 | 5.64 Million AUD | 0.0% |
| 2019 FY | 3.48 Million AUD | 142.19% |
| 2019 Q4 | 3.48 Million AUD | 0.0% |
| 2019 Q2 | 2.42 Million AUD | 0.0% |
| 2018 Q2 | 631.8 Thousand AUD | 0.0% |
| 2018 FY | 1.43 Million AUD | 12.15% |
| 2018 Q4 | 1.43 Million AUD | 0.0% |
| 2017 FY | 1.28 Million AUD | -23.6% |
| 2017 Q4 | 1.28 Million AUD | 0.0% |
| 2017 Q2 | 908.69 Thousand AUD | 0.0% |
| 2016 Q4 | 1.67 Million AUD | 0.0% |
| 2016 FY | 1.67 Million AUD | 21.45% |
| 2016 Q2 | 340.98 Thousand AUD | 0.0% |
| 2015 Q2 | 406.91 Thousand AUD | 0.0% |
| 2015 FY | 1.38 Million AUD | -27.2% |
| 2015 Q4 | 1.38 Million AUD | 0.0% |
| 2014 Q2 | 1.13 Million AUD | 0.0% |
| 2014 FY | 1.89 Million AUD | 172.09% |
| 2014 Q4 | 1.89 Million AUD | 0.0% |
| 2013 Q2 | 169.94 Thousand AUD | 0.0% |
| 2013 Q4 | 698.02 Thousand AUD | 319.08% |
| 2013 FY | 698.02 Thousand AUD | 184.94% |
| 2013 Q1 | 169.94 Thousand AUD | -30.63% |
| 2013 Q3 | 166.56 Thousand AUD | -1.99% |
| 2012 Q4 | 244.97 Thousand AUD | 0.0% |
| 2012 FY | 244.97 Thousand AUD | -48.99% |
| 2011 Q4 | 480.27 Thousand AUD | 0.0% |
| 2011 FY | 480.27 Thousand AUD | 56.25% |
| 2010 FY | 307.37 Thousand AUD | -29.62% |
| 2010 Q4 | 307.37 Thousand AUD | 0.0% |
| 2009 FY | 436.71 Thousand AUD | -11.48% |
| 2009 Q4 | 436.71 Thousand AUD | 0.0% |
| 2008 FY | 493.36 Thousand AUD | -11.99% |
| 2008 Q4 | 493.36 Thousand AUD | 0.0% |
| 2007 FY | 560.55 Thousand AUD | -30.46% |
| 2007 Q4 | 560.55 Thousand AUD | 0.0% |
| 2006 FY | 806.04 Thousand AUD | 95.87% |
| 2006 Q4 | 806.04 Thousand AUD | 0.0% |
| 2005 FY | 411.52 Thousand AUD | -29.57% |
| 2005 Q4 | 411.52 Thousand AUD | 0.0% |
| 2004 Q4 | 584.29 Thousand AUD | 0.0% |
| 2004 FY | 584.29 Thousand AUD | -16.62% |
| 2003 FY | 700.76 Thousand AUD | 1259.15% |
| 2003 Q4 | 700.76 Thousand AUD | 0.0% |
| 2002 Q4 | 51.55 Thousand AUD | 0.0% |
| 2002 FY | 51.55 Thousand AUD | -98.07% |
| 2001 Q4 | 2.66 Million AUD | 0.0% |
| 2001 FY | 2.66 Million AUD | 195.33% |
| 2000 Q4 | 903.08 Thousand AUD | 0.0% |
| 2000 FY | 903.08 Thousand AUD | 0.57% |
| 1999 Q4 | 898 Thousand AUD | 0.0% |
| 1999 FY | 898 Thousand AUD | -20.95% |
| 1998 FY | 1.13 Million AUD | -8.46% |
| 1997 Q4 | 1.24 Million AUD | 0.0% |
| 1997 FY | 1.24 Million AUD | 10.12% |
| 1996 FY | 1.12 Million AUD | -13.64% |
| 1995 FY | 1.3 Million AUD | 927.56% |
| 1994 FY | 127 Thousand AUD | -78.36% |
| 1993 FY | 587 Thousand AUD | 0.0% |
| Name | Total Liabilities | Total Liabilities Difference |
|---|---|---|
| EZZ Life Science Holdings Limited | 4.22 Million AUD | -683.691% |
| Anatara Lifesciences Ltd | 306.84 Thousand AUD | -10701.212% |
| Zelira Therapeutics Limited | 9.35 Million AUD | -254.225% |
| Biome Australia Limited | 5.37 Million AUD | -516.821% |
| Patrys Limited | 691.36 Thousand AUD | -4693.909% |
| Orthocell Limited | 22.08 Million AUD | -50.088% |
| Noxopharm Limited | 1.28 Million AUD | -2472.02% |
| PYC Therapeutics Limited | 10.18 Million AUD | -225.443% |
| Chimeric Therapeutics Limited | 12.8 Million AUD | -158.87% |
| Prescient Therapeutics Limited | 2.32 Million AUD | -1325.178% |
| Proteomics International Laboratories Limited | 1.62 Million AUD | -1938.434% |
| Cynata Therapeutics Limited | 1.17 Million AUD | -2730.218% |
| CSL Limited | 27.88 Billion AUD | 99.881% |
| Arovella Therapeutics Limited | 2.05 Million AUD | -1511.535% |
| Bio-Gene Technology Limited | 368.44 Thousand AUD | -8895.459% |
| Clinuvel Pharmaceuticals Limited | 28.11 Million AUD | -17.897% |
| Starpharma Holdings Limited | 8.69 Million AUD | -281.046% |
| Nanollose Limited | 465.64 Thousand AUD | -7017.773% |
| Memphasys Limited | 5.59 Million AUD | -492.652% |
| Invex Therapeutics Ltd | 431.63 Thousand AUD | -7578.662% |
| NeuroScientific Biopharmaceuticals Limited | 85.68 Thousand AUD | -38581.43% |
| Amplia Therapeutics Limited | 3.42 Million AUD | -867.183% |
| Botanix Pharmaceuticals Limited | 3.73 Million AUD | -788.069% |
| Island Pharmaceuticals Limited | 1.04 Million AUD | -3069.725% |
| Race Oncology Limited | 1.91 Million AUD | -1629.439% |
| Nyrada Inc. | 855.63 Thousand AUD | -3773.554% |
| Telix Pharmaceuticals Limited | 249.39 Million AUD | 86.71% |
| Dimerix Limited | 13.89 Million AUD | -138.561% |
| PharmAust Limited | 896.6 Thousand AUD | -3596.537% |
| Immutep Limited | 10.97 Million AUD | -201.864% |
| Clarity Pharmaceuticals Ltd | 8.33 Million AUD | -297.796% |
| Alterity Therapeutics Limited | 5.42 Million AUD | -510.861% |
| BTC Health Limited | 203.94 Thousand AUD | -16150.912% |
| Acrux Limited | 5.68 Million AUD | -482.793% |
| Neuren Pharmaceuticals Limited | 42.76 Million AUD | 22.495% |
| Biotron Limited | 737.5 Thousand AUD | -4393.973% |
| Tissue Repair Ltd | 1.35 Million AUD | -2353.425% |
| AdAlta Limited | 3.54 Million AUD | -835.579% |
| Radiopharm Theranostics Limited | 44.68 Million AUD | 25.826% |
| Hexima Limited | 248.67 Thousand AUD | -13228.27% |
| AnteoTech Limited | 4.07 Million AUD | -713.284% |
| Paradigm Biopharmaceuticals Limited | 3.58 Million AUD | -824.672% |
| Recce Pharmaceuticals Ltd | 15.89 Million AUD | -108.536% |
| Avecho Biotechnology Limited | 941.54 Thousand AUD | -3420.128% |
| Actinogen Medical Limited | 1.61 Million AUD | -1951.756% |
| Immuron Limited | 2.84 Million AUD | -1066.806% |
| Argenica Therapeutics Limited | 2.42 Million AUD | -1265.77% |